# A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

> **NCT00383890** · PHASE3 · COMPLETED · sponsor: **Hospira, now a wholly owned subsidiary of Pfizer** · enrollment: 124 (actual)

## Conditions studied

- Awake Fiberoptic Intubation

## Interventions

- **DRUG:** Dexmedetomidine HCL Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00383890
- **Lead sponsor:** Hospira, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-01
- **Final completion:** 2007-03
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2015-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383890, "A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00383890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*